Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1541 studies found for:    "Squamous cell carcinoma"
Show Display Options
Rank Status Study
21 Completed Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip
Conditions: Actinic Cheilitis;   Squamous Cell Carcinoma In-situ (SCC-is);   Squamous Cell Carcinoma (SCC);   Photodynamic Therapy (PDT);   Mohs Surgery
Intervention: Procedure: PDT prior to Mohs surgery
22 Completed Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IVA Salivary Gland Cancer;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Salivary Gland Cancer;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Salivary Gland Cancer;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Drug: ixabepilone;   Other: laboratory biomarker analysis
23 Recruiting Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Conditions: Cancer of Head and Neck;   Head and Neck Cancer;   Neoplasms, Head and Neck;   Carcinoma, Squamous Cell of Head and Neck;   Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma, Head and Neck
Interventions: Biological: MK-3475;   Procedure: Surgery;   Radiation: Intensity modulated radiation therapy;   Radiation: Image-guided radiation therapy;   Drug: Cisplatin
24 Active, not recruiting Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Conditions: Carcinoma, Squamous Cell of Head and Neck;   Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma, Head And Neck
Interventions: Drug: Ficlatuzumab;   Drug: Cetuximab
25 Active, not recruiting Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma
Conditions: Carcinoma, Squamous Cell of Head and Neck;   Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma, Head And Neck
Intervention: Biological: EGFR Antisense DNA
26 Terminated Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity
Interventions: Drug: erlotinib hydrochloride;   Radiation: intensity-modulated radiation therapy;   Other: pharmacogenomic studies;   Other: gene expression analysis;   Radiation: 3-dimensional conformal radiation therapy;   Other: biopsy;   Other: pharmacological study;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Other: enzyme-linked immunosorbent assay;   Other: polymorphism analysis
27 Recruiting Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Platin, 5-FU, Cetuximab, and Taxane
Conditions: Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma, Head and Neck
Interventions: Drug: Mitomycin-C;   Drug: Pegfilgrastim
28 Suspended Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma
Conditions: Oral Cavity Squamous Cell Carcinoma;   Oropharyngeal Squamous Cell Carcinoma
Intervention:
29 Completed Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Intervention:
30 Active, not recruiting Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Conditions: Salivary Gland Squamous Cell Carcinoma;   Stage II Salivary Gland Cancer;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Verrucous Carcinoma of the Oral Cavity
Interventions: Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Radiation: image-guided adaptive radiation therapy;   Other: 3'-deoxy-3'-[18F]fluorothymidine;   Procedure: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18
31 Completed A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Conditions: Squamous Cell Carcinoma of the Oral Cavity;   Squamous Cell Carcinoma of the Oropharynx
Intervention: Drug: GC4419
32 Not yet recruiting Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
Condition: Penile Squamous Cell Carcinoma
Intervention: Drug: Pembrolizumab
33 Completed
Has Results
Warning Signs of Squamous Cell Carcinoma and Prevention of SCC by at Risk Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Interventions: Behavioral: Educational Intervention;   Behavioral: Placebo
34 Completed
Has Results
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Condition: Squamous Cell Carcinoma
Intervention: Drug: Erlotinib
35 Unknown  The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
Conditions: Adenocarcinoma;   Squamous Cell Carcinoma;   Relevant Condition Terms to the Conditions Field
Intervention: Radiation: CT, radiation therapy
36 Completed Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head/Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: G-CSF;   Drug: Ciprofloxacin
37 Completed Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head and/or Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin
38 Active, not recruiting Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
Condition: Squamous Cell Carcinoma of Oropharynx
Interventions: Radiation: IMRT;   Drug: Cisplatin;   Drug: Carboplatin
39 Not yet recruiting Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck
Conditions: Head-and-neck Cancer;   Squamous Cell Carcinoma
Interventions: Drug: Docetaxel;   Radiation: Intensity-modulated radiotherapy
40 Recruiting Interest of Narrow Band Imaging in Detection of Upper Aerodigestive Cancers
Conditions: Squamous Cell Carcinoma of Oropharynx;   Squamous Cell Carcinoma of Hypopharynx;   Squamous Cell Carcinoma of Larynx
Intervention: Procedure: WL and NBI

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years